This article was originally published Feb. 3.
Helicos BioSciences said today that it will install a second Helicos Genetic Analysis system at Stanford University, and that it has sold an instrument to a private research institute, a deal originally announced a year ago.
The Stanford system will be installed in March and is intended to "meet the growing demand for access" to the company's single-molecule sequencing technology, according to Helicos. The firm shipped a first instrument to Stanford in 2008, where Helicos co-founder Steve Quake, a professor of bioengineering, used it last year to sequence and analyze his own genome.
Helicos originally announced the instrument order from the private research institute, the St. Laurent Institute, whose scientific director is Georges St. Laurent, in early 2009. The system's installation is expected to be completed early this month.
Originally, the instrument was to be shipped to the University of Maryland (see In Sequence 4/7/2009), but "the contractual terms were subsequently revised by Helicos to support SLI with a site for installation," Helicos said in a statement.
In addition to the two new placements, several existing Helicos customers are running increasing numbers of experiments on their systems, "which we expect will lead to the addition of multiple units at those sites," said CEO Ron Lowy.